Benzinga | Nov 15, 2021 06:04PM EST

ENDRA Life Sciences Q3 EPS $(0.06) Beats $(0.07) Estimate

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 60 percent increase over losses of $(0.15) per share from the same period last year.